Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Truscreen (ASX:TRU) is gaining momentum in a diverse range of jurisdictions
April 14, 2025
Truscreen (ASX:TRU)
We spoke to Marty Dillon, CEO of Truscreen (ASX:TRU) about the progress TRU has made in getting its TruScreen Cervical Cancer Screening Device to be used in multiple emerging markets.
Recent launches of approvals in places as diverse as Vietnam, Indonesia and Uzbekistan bode well for future revenues given the scale of potential screening programmes and the obvious advantages of TRU’s device.
Looking for the Best ASX Life Sciences stocks to invest in right now?
